Clinical Trials in Austin

Showing 4981-5000 of 15,205 trials

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152) as monotherapy or in combination in patients with solid tumors and aggressive non-hodgkin's lymphoma (NHL).

Neoplasms

Vincerx Pharma, Inc.110 participantsStarted Feb 2016

Springdale, Arkansas, United States • Louisville, Kentucky, United States • Silver Spring, Maryland, United States +13 more locations

COMPLETEDPhase 1/2< 1 mile

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

NCT05364021

The objective of this study is to assess the safety, tolerability, efficacy, and pharmacokinetics of adjunctive therapy of LP352 in adults and adolescents with developmental and epileptic encephalopathies.

Developmental and Epileptic EncephalopathyDravet SyndromeLennox Gastaut Syndrome

Longboard Pharmaceuticals52 participantsStarted Mar 2022

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Downey, California, United States +31 more locations

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

Find Trials by Condition in Austin

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions